One notable exception is histologically low-grade IDH-wild-type gliomas with isolated TERT promoter mutation, which have a statistically significantly better prognosis than classic IDH-wild-type GBM, arguing for caution when using isolated TERT promoter mutation as an independent diagnostic criterion [12]. The gene discussed is TERT; the disease is central nervous system cancer.